🇺🇸 FDA
Patent

US 10166244

Targeting NCCA-ATP channel for organ protection following ischemic episode

granted A61KA61K31/427A61K31/565

Quick answer

US patent 10166244 (Targeting NCCA-ATP channel for organ protection following ischemic episode) held by The United States of America as represented by the Department of Veteran Affairs expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Department of Veteran Affairs
Grant date
Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/427, A61K31/565, A61K31/57, A61K31/64